CD44 and hepatocellular carcinoma: GPC3 was a cell surface heparan sulfate proteoglycan that could enhance HCC cell migration via upregulating the expression under hypoxia states and interact with epithelial–mesenchymal transition-associated targets (Meng et al., 2021).